Conference Description:

Europe’s most established Proteins & Antibodies Congress will once again return to London to cover the latest development in protein & antibody engineering, design as well as key updates in biotherapeutics chemistry, analytics and control.

Over 450 proteins, antibodies, peptides and biosimilars & biobetters attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions

Over 50 case studies, presentations and panel discussions focused on the key issues in protein and antibody engineering & development, alternative scaffolds, protein & antibody biotherapeutics as well as biotherapeutics manufacturing and chemistry.

Including 6 interactive streams:

Protein Engineering, Design & Selection
Bioconjugates – ADC And Protein Fusion Therapeutics – Engineering, Safety And Clinical Considerations for Therapeutic Innovation
Antibody Engineering, Design & Development
Cloning, Expression & Purification, Crispr and Cell Engineering
Biotherapeutics: Manufacturing, Chemistry, Analytics and Control
Protein & Antibody Biotherapeutic Development Including Immuno-Oncology and Car T Cell Therapy